SEARCH

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policies, and Terms of Service.

    US Proposal Could Halve Biocon's Biosimilar Development Costs

    11 hours ago

    India's Biocon expects a 50% drop in costs for developing complex biosimilars as the United States has proposed to ease clinical testing for the drugs that make up more than 60% of its revenue, a top executive said on Wednesday.
    Click here to Read more
    Prev Article
    'Ensure Young Ukrainian Men Don't Come To Germany': Chancellor To Zelensky
    Next Article
    How is SEC ensuring fair elections? | Explained

    Related World Updates:

    Comments (0)

      Leave a Comment